Association of HLA class II genes with systemic sclerosis in Koreans

Journal of Rheumatology

Volumn 28, Issue 7, 2001, Pages 1577-1583

  Sung Ha Kang, ^a   Myoung Hee Park, ^a   Eun Young Song, ^a   Su Jin Kang, ^a   Eun Bong Lee, ^a   Yeong Wook Song, ^a   Takeuchi, F ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

HLA DQ; HLA DR; Korean; Systemic sclerosis

Indexed keywords

DNA TOPOISOMERASE; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; RIBONUCLEOPROTEIN;

ADULT; AGED; ARTICLE; CENTROMERE; CLINICAL FEATURE; DISEASE ASSOCIATION; ETHNOLOGY; FEMALE; GENE; HUMAN; IMMUNOGENETICS; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ADULT; AGED; AUTOANTIBODIES; CENTROMERE; DNA TOPOISOMERASES, TYPE I; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; KOREA; MALE; MIDDLE AGED; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; SCLERODERMA, SYSTEMIC;

EID: 0034939160     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis
2. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I: A study of 355 patients
3. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis
4. Immunogenetic associations of scleroderma-related antinuclear antibodies
5. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis
6. Molecular genetics of systemic sclerosis
7. HLA and autoimmunity in scleroderma (systemic sclerosis)
8. Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis
9. Association of amino acid sequence in HLA-DQB1 first domain with the antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis)
10. Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele
11. HLA association in three exclusive autoantibody subgroups in UK systemic sclerosis patients
12. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma)
13. Association of HLA-DR with progressive systemic sclerosis in Japanese
14. Increased prevalence of systemic sclerosis in a native American tribe in Oklahoma. Association with an Amerindian HLA haplotype
15. Association of polar amino acid at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma)
16. Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: A serological and HLA study
17. Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma
18. Racial differences in the frequencies of scleroderma-related autoantibodies
19. Frequencies of scleroderma-related autoantibodies in patients meeting the American College of Rheumatology criteria for systemic sclerosis
20. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies
21. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody
22. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
23. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
24. Systemic sclerosis (scleroderma): Clinical aspects
25. Discrimination of human HLA-DRB1 alleles by PCR-SSCP method
26. High resolution HLA-DQB1 typing by combination of PCR-RFLP and PCR-SSCP
27. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors
28. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups
29. T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis
30. Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis
31. HLA and clinical association in systemic sclerosis patients with anti-Th/To antibodies
32. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis
33. Autoantibody reactive with RNA polymerase III in systemic sclerosis